Valerio Therapeutics bids €30M for Etherna Immunotherapies
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Valerio Therapeutics SA (ALVIO)
Valerio Therapeutics SA stock price live, this page displays EPA ALVIO stock exchange data. View the ALVIO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Valerio Therapeutics SA real time stock price chart below.
What Is the Valerio Therapeutics SA Stock Price Today?
The Valerio Therapeutics SA stock price today is 0.7410.
What Is the Stock Symbol for Valerio Therapeutics SA?
The stock symbol for Valerio Therapeutics SA is "ALVIO."
What Stock Exchange Does Valerio Therapeutics SA Trade On?
Valerio Therapeutics SA is listed and trades on the Paris stock exchange.
Is Valerio Therapeutics SA a Good Stock to Buy?
Determining whether Valerio Therapeutics SA, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALVIO quote. (ISIN: FR0010095596)
What Is the Valerio Therapeutics SA Stock Price Today?
The Valerio Therapeutics SA stock price today is 0.7410.
What Is the Stock Symbol for Valerio Therapeutics SA?
The stock symbol for Valerio Therapeutics SA is "ALVIO."
What Stock Exchange Does Valerio Therapeutics SA Trade On?
Valerio Therapeutics SA is listed and trades on the Paris stock exchange.
Is Valerio Therapeutics SA a Good Stock to Buy?
Determining whether Valerio Therapeutics SA, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALVIO quote. (ISIN: FR0010095596)
0.7410
-0.0080(-1.07%)
Closed·
Fair Value
An estimate of a Valerio Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7040
0.7760
52 wk Range
0.0570
0.9800
ALVIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Valerio Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.70400.7760
52 wk Range
0.05700.9800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALVIO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Valerio Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Earnings
Latest Release
Apr 28, 2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
2.45M / --
Compare ALVIO to Peers and Sector
Metrics to compare | ALVIO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALVIOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −75.6x | −2.9x | −0.3x | |
PEG Ratio | −0.86 | −0.07 | 0.00 | |
Price/Book | 178.3x | 1.3x | 2.6x | |
Price / LTM Sales | 143.8x | 20.1x | 3.0x | |
Upside (Analyst Target) | - | 149.2% | 56.7% | |
Fair Value Upside | Unlock | 1.2% | 9.4% | Unlock |
Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies. The company develops PlatON, a proprietary chemical platform for DNA decoy therapies, which generates new compounds and broadens its product portfolio; DecoyTAC, a mechanism of action of DNA decoy therapies coupled with targeted protein degradation; and V-body platform, a bispecific T-cell engagers, antibody– drug conjugates, and chimeric antigen receptors. The company was formerly known as Onxeo SA and changed its name to Valerio Therapeutics Société anonyme in June 2023. Valerio Therapeutics Société anonyme was incorporated in 1997 and is headquartered in Paris, France.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Valerio Therapeutics (ALVIO) Stock Price Today?
The Valerio Therapeutics stock price today is 0.7410 EUR.
What Stock Exchange Does Valerio Therapeutics Trade On?
Valerio Therapeutics is listed and trades on the Paris Stock Exchange.
What Is the Stock Symbol for Valerio Therapeutics?
The stock symbol for Valerio Therapeutics is "ALVIO."
What Is the Valerio Therapeutics Market Cap?
As of today, Valerio Therapeutics market cap is 370.0900M EUR.
What Is Valerio Therapeutics's Earnings Per Share (TTM)?
The Valerio Therapeutics EPS (TTM) is -0.0200.
From a Technical Analysis Perspective, Is ALVIO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Valerio Therapeutics Stock Split?
Valerio Therapeutics has split 4 times.
How Many Employees Does Valerio Therapeutics Have?
Valerio Therapeutics has 25 employees.
What is the current trading status of Valerio Therapeutics (ALVIO)?
As of Aug 01, 2026, Valerio Therapeutics (ALVIO) is trading at a price of 0.7410 EUR, with a previous close of 0.7490 EUR. The stock has fluctuated within a day range of 0.7040 EUR to 0.7760 EUR, while its 52-week range spans from 0.0570 EUR to 0.9800 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.